Comparison between Dr Lalchandani Labs IPO and Garv Industries IPO.
Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while Garv Industries IPO is a SME Fixed Price proposed to list at BSE SME.
| Dr Lalchandani Labs IPO | Garv Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Navigant Corporate Advisors Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Cameo Corporate Services Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the Garv Industries IPO is up to ₹3.03 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Garv Industries IPO is ₹10.00 per share.
| Dr Lalchandani Labs IPO | Garv Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹30.00 per share | ₹10.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 10000 shares |
| Fresh Issue Size | 13,28,000 shares | 30,30,000 shares |
| Fresh Issue Size (Amount) | up to ₹3.98 Cr | up to ₹3.03 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,28,000 shares | 30,30,000 shares |
| Issue Size Total (Amount) | up to ₹3.98 Cr | up to ₹3.03 Cr |
Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Garv Industries IPO opens on Apr 12, 2018. The closing date of Dr Lalchandani Labs IPO and Garv Industries IPO is Apr 27, 2018, and Apr 17, 2018, respectively.
| Dr Lalchandani Labs IPO | Garv Industries IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 25, 2018 | Apr 12, 2018 |
| Issue Close | Apr 27, 2018 | Apr 17, 2018 |
| Basis Of Allotment (Tentative) | Apr 20, 2018 | |
| Initiation of Refunds (Tentative) | Apr 23, 2018 | |
| Credit of Share (Tentative) | Apr 24, 2018 | |
| Listing date (Tentative) | May 09, 2018 | Apr 25, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dr Lalchandani Labs IPO P/E ratio is , as compared to Garv Industries IPO P/E ratio of .
| Dr Lalchandani Labs IPO | Garv Industries IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹13.00 Cr. | ₹10.20 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in Garv Industries IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered in Dr Lalchandani Labs IPO and in Garv Industries IPO.
| Dr Lalchandani Labs IPO | Garv Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 72,000 shares | 1,70,000 shares |
| QIB | ||
| NII | 6,64,000 shares | 15,15,000 shares |
| RII | 6,64,000 shares | 15,15,000 shares |
| Employee | ||
| Others | ||
| Total | 13,28,000 shares | 30,30,000 shares |
Dr Lalchandani Labs IPO subscribed 4.63x in total, whereas Garv Industries IPO subscribed 2.13x.
| Dr Lalchandani Labs IPO | Garv Industries IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.13x | 2.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 6.13x | 1.98x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.63x | 2.13x |
